Log in to save to my catalogue

Synbiotics as a novel therapeutic approach for hyperphosphatemia and hyperparathyroidism in chronic...

Synbiotics as a novel therapeutic approach for hyperphosphatemia and hyperparathyroidism in chronic...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9babeaf468a9494bab3121ede69c9f65

Synbiotics as a novel therapeutic approach for hyperphosphatemia and hyperparathyroidism in chronic kidney disease rats

About this item

Full title

Synbiotics as a novel therapeutic approach for hyperphosphatemia and hyperparathyroidism in chronic kidney disease rats

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2025-03, Vol.15 (1), p.7493-10, Article 7493

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Hyperphosphatemia and secondary hyperparathyroidism (SHPT) are the common complications found in CKD that lead to severe complications including mineral bone disease (MBD), vascular calcification (VC), and cardiovascular mortality. To mitigate hyperphosphatemia, SHPT and uremic toxemia, we supplemented cisplatin-induced CKD rats with a synbiotic co...

Alternative Titles

Full title

Synbiotics as a novel therapeutic approach for hyperphosphatemia and hyperparathyroidism in chronic kidney disease rats

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9babeaf468a9494bab3121ede69c9f65

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9babeaf468a9494bab3121ede69c9f65

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-025-91033-9

How to access this item